Health News Releases

  • Today July 2
May 29, 09:14
Pimicotinib Demonstrates Best-in-Class Potential with Significant Efficacy and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumor
Merck, a leading science and technology company, today announced the presentation of detailed positive results from Part 1 of the global Phase 3 MANEUVER trial evaluating pimicotinib, a potentially be
Nurse Naomi Oyoe Ohene Oti from Ghana – Winner of Aster Guardians Global Nursing Award 2025 (Photo:
May 28, 16:50
Ghana’s Naomi Oyoe Ohene Oti Wins Aster Guardians Global Nursing Award 2025 Worth USD 250,000
Nurse Naomi Ohene Oti from Ghana has been named the winner of the Aster Guardians Global Nursing Award 2025, selected from 100,000 applications from 199 countries. An Oncology Nurse Specialist and Hea
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific adv
May 28, 16:00
New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug deve
key visual image
May 28, 16:00
Revolutionizing Healthcare: Ubitus and MacKay Memorial Hospital Present AI Robot Collaboration at GTC Taiwan
Ubitus, a global leader in cloud streaming and AI solutions, announced its collaboration with MacKay Memorial Hospital to unveil AI-powered multi-modal medical robots at NVIDIA GTC Taiwan 2025. The pr
May 28, 14:32
Galderma Buys Back Shares Worth CHF 233 Million in the Context of Accelerated Bookbuild Offering
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 2.38 million shares at a price of CHF 97.75 per share for a total consideration of CHF
May 28, 09:05
Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba
Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR · Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of
May 28, 08:44
Takeda and Nature Announce Call for Applications Now Open for 2026 Innovators in Science Award
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54259352&newsitemid=20250527716937&lan=en-US&anchor=TSE%3A4
May 27, 17:06
World-Leading Cancer Center, The Royal Marsden NHS Foundation Trust, Using AI to Push Boundaries of Cancer Research With NTT DATA and CARPL.ai
The Royal Marsden NHS Foundation Trust (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.royalmarsden.nhs.uk%2F&esheet=54258962&newsitemid=20250527348807&lan=en-US&anchor=The+Roya
May 25, 14:25
BeiGene Presents Pioneering Cancer Research at ASCO 2025 - Redefining Treatment Across Hematology and Solid Tumors
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54258273&newsitemid=20250522213317&lan=en-US&anchor=BeiGene&index=1&md5=b2e553cdb745c6a1895871c2f51
May 23, 13:55
Rubedo Life Sciences Announces First Patient Dosed with Lead Drug Candidate RLS-1496, the First GPX4 Modulator Targeting Pathologic Senescent Cells To Enter Phase 1 Clinical Trial
Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced
May 23, 11:30
Merck Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO) Annual M
May 23, 11:30
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 2025
CCM Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3973906-1%26h%3D3084432827%26u%3Dhttps%253A%252F%252Fwww.ccm-bio.com%25
May 23, 10:45
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025
CCM Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3973906-1%26h%3D3084432827%26u%3Dhttps%253A%252F%252Fwww.ccm-bio.com%25
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific adv
May 22, 15:25
Novotech Honored with Triple Win in 2025 Pharmaceutical Technology Excellence Awards
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies, is proud to announce its
May 22, 08:40
Merck Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with Active Lupus Rash
Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced positive data on enpatoran, an investigational, oral, novel TLR7/8 inhibitor, demons
May 18, 15:15
Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) te
May 18, 15:00
Everyday Care in Action: Thousands of Kenvue Employees Come Together Across 21 Markets to Help Advance Healthier Communities
Kenvue Inc. (NYSE: KVUE), the maker of iconic brands such as Neutrogena®, Listerine®, Aveeno®, and Tylenol®, today announced its global community engagement efforts in celebration of Kenvue Cares Week
May 18, 12:55
The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1
Takeda (TSE: 4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the New England Journal of Medicine (https://www.nejm.org/doi/full/10.1056/NEJMoa2405847) published data f
May 16, 17:20
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)
GSK plc (LSE/NYSE: GSK) and Boston Pharmaceuticals, a leading clinical stage biopharmaceutical company developing highly targeted therapies for patients with serious liver diseases, today announced th
Image created by Clara Leibenguth for Stanford University; featured on cover of May 2025 issue of Na
May 16, 17:00
Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience
Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced
May 16, 15:00
Ecolab Life Sciences Opens New State-of-the-Art Bioprocessing Applications Laboratory in Pennsylvania, US
Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania. The new facility is designed to support biopharma customers with applic
71.4% of MetaXplore™ reports from 4,616 patients identified actionable results
May 16, 14:35
Microba Announces Landmark GI Study Results From Over 4,600 Patients
Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”), a precision microbiome company, today announces preliminary results from the analysis of over 4,600 MetaXplore™ GI Plus (https://
Dr. Jerome Kim, Director General of IVI (left), standing next to TriLink’s Chief Commercial Officer,
May 15, 16:30
TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines
Today, TriLink BioTechnologies (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.trilinkbiotech.com%2F&esheet=54254971&newsitemid=20250514331075&lan=en-US&anchor=TriLink+BioTechno
Novotech is proud to announce it has been awarded the Citeline CRO Partnership of the Year Award in
May 14, 13:30
Novotech Wins Citeline CRO Partnership of the Year Award for Strategic Collaboration with Tune Therapeutics
Novotech a globally recognized full-service clinical research organization (CRO) and scientific advisory company, is proud to announce it has been awarded the Citeline CRO Partnership of the Year Awar
HistoSonics Edison Histotripsy System
May 13, 15:30
HistoSonics Secures First Major Insurance Coverage for Non-Invasive Histotripsy Treatment for Liver Tumors With Blue Cross Blue Shield of Michigan
HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhistosonics.com%2F&esheet=54252813&newsitemid=20250512714050&lan=en-US&anchor=HistoSonics&index=1&md5=41ec7eed6a70eb897ae
May 09, 15:10
BeiGene Announces First Quarter 2025 Financial Results and Business Updates
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54250156&newsitemid=20250507583971&lan=en-US&anchor=BeiGene&index=1&md5=4f57ade9dfc9fe1fd6bc4495287
May 09, 14:30
Novotech Analysis Highlights Rising Clinical Development Efforts for Obesity Treatments
Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, has published a report analyzing recent trends in obesity-related clinical trials. The report shows tha
WHOOP Unveils Next Generation WHOOP® 5.0 and WHOOP® MG
May 09, 13:50
WHOOP Unveils WHOOP® 5.0 and WHOOP® MG: Powerful New Devices with Breakthrough Health and Longevity Features
WHOOP (https://www.whoop.com/ie/en/), the human performance company, today introduces WHOOP 5.0 and WHOOP MG — two next-generation wearables designed to unlock a new approach to personal health and lo
May 09, 13:40
GC Aesthetics® Strengthens Board of Directors with Strategic Appointments
GC Aesthetics® (GCA), a privately-held medical technology company providing aesthetic and reconstruction solutions for global healthcare markets is pleased to announce the appointment of Mr. Luigi Fer
Professor Sebastian Johnston
May 08, 17:10
Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials
VirTus Respiratory Research Ltd, a leading respiratory-focused contract research organisation (CRO), today announced that results from their human rhinovirus challenge model in patients with chronic o
May 08, 17:06
Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline Progress
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54244498&newsitemid=20250427084429&lan=en-US&anc
May 08, 16:40
ELIQUENT Life Sciences Announces Strategic Acquisition of Azzur Consulting - Strengthening Full-Service Quality & Compliance Capabilities
ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the acquisition of Azzur Consulting, a leading quality and validation engineering firm. Thi
Rimini Street and ServiceNow Partner with Apsen Farmacêutica to Deliver a Next-Generation Vision of
May 08, 09:22
Rimini Street and ServiceNow Partner with Apsen Farmacêutica to Deliver a Next-Generation Vision of Enterprise-Wide Workflow Automation
Knowledge 2025 — Rimini Street, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.riministreet.com%2F%3Futm_source%3Dpressrelease%26utm_medium%3DReferral%26utm_campaign%3DAsp
Chris O'Connell, Chairman, Board of Directors, CorFlow
May 07, 17:00
CorFlow Therapeutics Appoints Chris O'Connell as Chairman of the Board of Directors
CorFlow Therapeutics AG (https://corflow.com/) (CorFlow) is pleased to announce the appointment of Chris O’Connell as Chairman of the Board of Directors, replacing Rick Geoffrion who remains as a Dire
Top 10 finalist nurses for Aster Guardians Global Nursing Award 2025 (Photo: AETOSWire)
May 07, 16:15
Aster Guardians Global Nursing Award Unveils Top 10 Finalists for 2025
The Aster Guardians Global Nursing Award has today announced its Top 10 finalists for 2025, one of whom will go on to win the grand prize of USD 250,000. The finalists for the fourth edition of the aw
May 06, 12:20
U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54246103&newsitemid=20250429590949&lan=en-US&anchor=BeiGene&index=1&md5=0c09798a0c67c852789b965c290
Microba Delivers Landmark IBD Results & Signs Major Gastro Partner
May 06, 11:40
Microba Delivers Landmark IBD Results & Signs Major Gastro Partner
Microba Life Sciences Limited (ASX: MAP) (“Microba”) a precision microbiome company, today announces two significant developments: the release of new clinical utility results for its MetaPanel™ gastro
PCI Pharma Services enhances US manufacturing of prefilled syringes & cartridges through acquisition
May 06, 11:00
Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges
PCI Pharma Services (“PCI”) - a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies - has completed its acquisition of Ajinomoto Althea,
May 06, 10:40
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets
Prilenia Therapeutics B.V. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.prilenia.com%2F&esheet=54244101&newsitemid=20250425385230&lan=en-US&anchor=Prilenia+Therapeutics+B.V.&
Kumar Ramu, Senior Vice President & Managing Director, QPS India.
May 02, 15:20
QPS India Successfully Completes Week-Long US FDA Regulatory Inspection
QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by successfully completing an uns
Robert Dempsey, Chairman of the Board, Azalea Vision
April 30, 17:20
Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform
Azalea (A-zuh-lay-ah) Vision, a HealthTech company engineering the future of sight, today announced the first closing of its €15 million Series A funding round, raising €9 million along with the appoi
April 30, 15:41
SINOVAC Announces Record and Distribution Dates for Special Cash Dividend
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that a special dividend of US$55.00 per common share, as pre
April 30, 09:50
HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials
HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhistosonics.com%2F&esheet=54244430&newsitemid=20250428931117&lan=en-US&anchor=HistoSonics&index=1&md5=654c6b5b28f131e64dc
April 29, 17:10
SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the “Board”) issued a public le
Sparta, WI Facility
April 29, 15:30
Actus Nutrition Acquires Protein Facility from Foremost Farms USA
Actus Nutrition (“Actus”), a leading vertically-integrated nutritional ingredients manufacturer and portfolio company of Butterfly Equity (“Butterfly”), today finalized an agreement to purchase a 99,0
April 29, 09:50
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine
Ferrer (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ferrer.com&esheet=54244013&newsitemid=20250427034068&lan=en-US&anchor=Ferrer&index=1&md5=d54ab3f5c9071597c756ac15dea5202e),
VIO 3n Fire
April 27, 11:30
Erbe introduces VIO® 3n & VIO® seal: Tailored electrosurgical generators for high-performance workflows
With the introduction of the VIO® 3n, Erbe Elektromedizin GmbH expands its established VIO® 3 family with a new generation of electrosurgical generators, specifically tailored to different medical spe
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea.
April 25, 10:00
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
PCI Pharma Services (“PCI”) - a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies - is acquiring an entire equity stake in Ajinomoto A
April 24, 16:10
Grant Award from GHIT Fund for Development of an Ultrasensitive Urine Test for Tuberculosis
H.U. Group Holdings, Inc. and its wholly-owned subsidiary Fujirebio Holdings, Inc. today announced that the Global Health Innovative Technology (GHIT) Fund has awarded a two-year, approximately $4.5 m
April 24, 14:15
Galderma Delivers Record First Quarter Net Sales of 1.129 Billion USD, Including Strong Performance From Two Launches With Blockbuster Potential, and Confirms Full-Year Guidance
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2025. · Net sales: Achieved 1,129 million USD in net sales, u
25 per page50 per page75 per page100 per page